Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines

Prostate

Volumn 29, Issue 6, 1996, Pages 386-394

  Webber, Mukta M ^a   Bello, Diana ^a   Quader, Salmaan ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

androgen receptor; androgen responsiveness; cytokeratins; growth factors; human papillomavirus; immortalized cell lines; prostate cancer; prostate specific antigen

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BLOOD CLOTTING FACTOR 8; CELL MARKER; CYTOKERATIN; DESMIN; GROWTH FACTOR; PROSTATE SPECIFIC ANTIGEN;

CANCER INVASION; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; CELL TRANSFORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REVIEW; SIMIAN VIRUS 40; TUMOR GROWTH; WART VIRUS;

ADENOVIRUSES, HUMAN; ADULT; CELL LINE; DESMIN; EPITHELIUM; HUMANS; KERATINS; MALE; PAPILLOMAVIRIDAE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIMIAN VIRUS 40; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030472709     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6     Document Type: Review

References (51)

1. Webber MM: In vitro models for prostate cancer: Summary. In Murphy GP (ed): "Models for Prostate Cancer." Progr Clinical Biol Res 37:133-147, 1980.
2. Webber MM: Normal, benign and malignant human prostatic epithelium: In vitro cell models for studies on the etiology, treatment, and prevention of benign and malignant human prostatic neoplasia. In Webber MM, Sekely LI (eds): "In Vitro Models for Cancer Research. Carcinoma of the Prostate and Testis." Vol. V. Boca Raton, FL: CRC Press, 1988, pp 25-103.
3. Carter BS, Carter HB, Isaacs JT: Epidemiological evidence regarding predisposing factors to prostate cancer. Prostate 16:187-197, 1990.
4. Webber MM, Weiner SM, Rehman SMM, Wettlaufer JN: Carcinoma of the prostate: Geographic distribution and risk factors. In Webber MM, Sekely LI (eds): "In Vitro Models for Cancer Research. Carcinoma of the Prostate and Testis," Vol V. Boca Raton, FL: CRC Press, 1988, pp 3-24.
5. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46:5-28, 1996.
6. Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA Cancer J Clin 40:9-26, 1990.
7. Chaproniere-Rickenberg DM, Webber MM: A chemically defined medium for the growth of adult human prostatic epithelium. In Sato GH, Pardee AB, Sirbasku DA (eds): "Growth of Cells in Hormonally Defined Media." Cold Spring Harbor Conference on Cell Proliferation. Book B. Vol. 9. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982, pp 1109-1115.
8. Hedlund TE, Miller GJ: A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate 24:221-228, 1994.
9. Kaighn ME, Lechner JF, Babcock MS, Marnell M, Ohnuki Y, Narayan KS: The Pasadena cell lines. In Murphy GP (ed): "Models for Prostate Cancer." Progr Clinical Biol Res 37:85-109, 1980.
10. McKeehan WL, Adams PS, Rosser MP: Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44:1998-2010, 1984.
11. Peehl DM, Wong ST, Stamey TA: Clonal Growth Characteristics of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 24:530-536, 1988.
12. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS: Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 17:1641-1646, 1996.
13. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 (submitted), 1996.
14. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen L, Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 91:11874-11878, 1994.
15. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C: Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 143:167-171, 1990.
16. Truong LD, Rangdaeng S, Cagle P, Ro JY, Hawkins H, Font RL: The diagnostic utility of desmin: A study of 584 cases and review of the literature. Am J Clin Pathol 93:305-314, 1990.
17. Fajardo LF: Special Report: The complexity of endothelial cells. Am J Clin Pathol 92:241-250, 1989.
18. Chen HZ, Kirschenbaum A, Mandeli J, Hollander VP: The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP. Steroids 57:269-275, 1992.
19. Fong CJ, Sherwood ER, Sutkowski DM, Abu-Jawdeh GM, Yokoo H, Bauer KD, Kozlowski JM, Lee C: Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells. Prostate 19:221-235, 1991.
20. Berns EMJJ, de Boer W, Mulder E: Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9:247-259, 1986.
21. Schulz P, Wolf D, Arbusow V, Bojar H, Klobeck HG, Fittler F: The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line. Andrologia 22(suppl 1):56-66, 1990.
22. Schuurmans AL, Bolt J, Veldscholte J, Mulder E: Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197, 1991.
23. Watt KWK, Lee P-J, M'Timkulu T, Chan W-P, Loor R: Human prostate-specific antigen: Structural and func-tional similarity with serine proteases. Proc Natl Acad Sci USA 83:3166-3170, 1986.
24. Webber MM, Waghray A, Bello D: Prostate specific antigen (PSA), a serine protease, facilitates human prostate cancer invasion. Clin Cancer Res 1:1089-1094, 1995.
25. Guo Y, Pili R, Passaniti A: Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix. Prostate 24:1-10, 1994.
26. Langeler EG, van Uffelen C JC, Blankenstein MA, van Steenbrugge GJ, Mulder E: Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate 23:213-23, 1993.
27. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM: Regulation of proliferation and production of prostate specific antigen in androgen-sensitive prostatic cancer cell, LNCaP, by dihydrotestosterone. Endocrinology 136: 796-803, 1995.
28. Krongrad A, Wilson CM, Wilson JD, Allman DR, McPhaul MJ: Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76:79-88, 1991.
29. Jänne OA, Palvimo JJ, Kallio P, Mehto M: Androgen receptor and mechanisms of androgen action. Ann Med 25:84-89, 1993.
30. van Laar JH, Vries JB, Voor-Ogink MM, Brinkmann AO: The human androgen receptor is a 110 kDa protein. Mol Cell Endocrinol 63:39-44, 1989.
31. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A: Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res 53:1304-1311, 1993.
32. Mulder E, van Loon D, de Boer W, Schuurmans AL, Bolt J, Voorhorst MM, Kuiper GG, Brinkmann AO: Mechanism of androgen action: Recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells. J Steroid Biochem 32:151-156, 1989.
33. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, Brinkman AO, Mulder E: The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669, 1992.
34. Brolin J, Skoog L, Ekman P: Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20:281-295, 1992.
35. Castagnetta L, Carruba G, Granata OM, Lo Casto M, Arcuri F, Mesiti M, Pavone-Macaluso M: Prostate long-term epithelial cell lines: Biological and biochemical features. Ann NY Acad Sci 595:149-164, 1990.
36. Katsuoka Y, Hoshino H, Shiramizu M, Sakabe K, Seiki K: Autoradiographic and cytochemical localization of androgen in human prostatic cancer cell lines. Invest Urol 28:228-231, 1986.
37. Sica G, Dell'Acqua G, Iacopino F, Fattorossi A, Marchetti P, van der Kwast TH, Pavone-Macaluso M: Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon. Urol Res 22:33-38, 1994.
38. Sadi MV, Walsh PC, Barrack ER: Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67:3057-3064, 1991.
39. Liu XH, Wiley HS, Meikle AW: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J Clin Endocrinol Metab 77:1472-1478, 1993.
40. Saroff J, Kirdani RY, Ming Chu T, Wajsman Z, Murphy GP: Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 37:46-52, 1980.
41. 3. Cancer Res 52: 515-520, 1992.
42. Mickey DD, Stone KR, Wunderli H, Mickey G, Paulson DF: Characterization of a human prostate adenocarcinoma cell line (DU-145) as a monolayer culture and a solid tumor in athymic mice. Prog Clin Biol Res 37:67-84, 1980.
43. Kokontis J, Takakura K, Hay N, Liao S: Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res 54:1566-1573, 1994.
44. Iwamura M, Sluss PM, Casamento JB, Cockett ATK: Insulin-like growth factor 1: Action and receptor characterization in human prostate cancer cell lines. Prostate 22:243-252, 1993.
45. Keer HN, Kozlowski JN, Tsai YC, Lee C, McEwan RN, Grayhack JT: Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 143:381-385, 1990.
46. Israeli RS, Powell CT, Corr JG, Fair WR, Heston DW: Expression of the prostate-specific membrane antigen. Cancer Res 54:1807-1811, 1994.
47. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A, Calvo F: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 143: 881-886, 1991.
48. Lee M, Garkovenko E, Yun JS, Weijerman PC, Peehl DM, Chen L, Rhim JS: Characterization of adult human prostatic epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective SV40 genome. Int J Oncol 4:821-830, 1994.
49. Webber MM: Normal and benign human prostatic epithelium in culture. I. Isolation. In Vitro 15:967-982, 1979.
50. Weijerman PC, König JJ, Wong ST, Niesters HGM, Peehl DM: Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 54:5579-5583, 1994.
51. Peehl DM, Wong ST, Rhim JS: Altered growth regulation of prostatic epithelial cells by human papillomavirus-induced transformation. Int J Oncol 6:1177-1184, 1995.